Wall Street brokerages expect Endo International PLC (NASDAQ:ENDP) (TSE:ENL) to post $0.45 earnings per share (EPS) for the current quarter, Zacks reports. Five analysts have issued estimates for Endo International’s earnings, with the lowest EPS estimate coming in at $0.36 and the highest estimate coming in at $0.66. Endo International posted earnings per share of $0.67 in the same quarter last year, which would indicate a negative year over year growth rate of 32.8%. The business is expected to issue its next earnings results on Tuesday, May 14th.
According to Zacks, analysts expect that Endo International will report full year earnings of $2.24 per share for the current fiscal year, with EPS estimates ranging from $2.05 to $2.81. For the next financial year, analysts forecast that the business will report earnings of $2.39 per share, with EPS estimates ranging from $1.78 to $3.12. Zacks Investment Research’s EPS calculations are an average based on a survey of sell-side research analysts that cover Endo International.
Endo International (NASDAQ:ENDP) (TSE:ENL) last announced its quarterly earnings results on Thursday, February 28th. The company reported $0.75 EPS for the quarter, beating the consensus estimate of $0.59 by $0.16. Endo International had a negative net margin of 35.00% and a negative return on equity of 337.13%. During the same period last year, the company earned $0.77 EPS.
A number of institutional investors have recently bought and sold shares of ENDP. Norges Bank acquired a new position in Endo International in the 4th quarter worth approximately $21,218,000. Panagora Asset Management Inc. boosted its stake in Endo International by 10,718.5% in the 3rd quarter. Panagora Asset Management Inc. now owns 1,775,205 shares of the company’s stock worth $29,877,000 after purchasing an additional 1,758,796 shares during the period. Teachers Advisors LLC boosted its stake in Endo International by 230.1% in the 3rd quarter. Teachers Advisors LLC now owns 1,468,025 shares of the company’s stock worth $24,707,000 after purchasing an additional 1,023,350 shares during the period. Canada Pension Plan Investment Board boosted its stake in Endo International by 143,723.6% in the 4th quarter. Canada Pension Plan Investment Board now owns 730,624 shares of the company’s stock worth $5,333,000 after purchasing an additional 730,116 shares during the period. Finally, Oregon Public Employees Retirement Fund acquired a new position in Endo International in the 4th quarter worth approximately $76,000. 98.25% of the stock is owned by hedge funds and other institutional investors.
Shares of NASDAQ ENDP traded up $0.01 during mid-day trading on Friday, reaching $8.42. 1,488,832 shares of the company traded hands, compared to its average volume of 3,429,484. Endo International has a fifty-two week low of $5.27 and a fifty-two week high of $18.50. The firm has a market capitalization of $1.88 billion, a PE ratio of 2.91 and a beta of 1.21.
Endo International Company Profile
Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States, Canada, and internationally. The company operates through three segments: U.S. Generic Pharmaceuticals, U.S. Branded Pharmaceuticals, and International Pharmaceuticals.
See Also: 12b-1 Fees
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Endo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endo International and related companies with MarketBeat.com's FREE daily email newsletter.